<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ullrich <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> (UCMD) and Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> are inherited <z:e sem="disease" ids="C0026848" disease_type="Disease or Syndrome" abbrv="">muscle disorders</z:e> caused by mutations of genes encoding the extracellular matrix protein collagen VI (ColVI) </plain></SENT>
<SENT sid="1" pm="."><plain>Mice lacking ColVI (Col6a1(-/-)) display a myopathic phenotype associated with ultrastructural alterations of mitochondria and sarcoplasmic reticulum, <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction with abnormal opening of the permeability transition pore (<z:chebi fb="0" ids="52242">PTP</z:chebi>) and <z:mp ids='MP_0006042'>increased apoptosis</z:mp> of muscle fibers </plain></SENT>
<SENT sid="2" pm="."><plain>Treatment with cyclosporin (Cs) A, a drug that desensitizes the <z:chebi fb="0" ids="52242">PTP</z:chebi> by binding to cyclophilin (Cyp)-D, was shown to rescue myofiber alterations in Col6a1(-/-) mice and in UCMD patients, suggesting a correlation between <z:chebi fb="0" ids="52242">PTP</z:chebi> opening and pathogenesis of ColVI <z:hpo ids='HP_0003560'>muscular dystrophies</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we show that inactivation of the gene encoding for Cyp-D rescues the disease phenotype of ColVI deficiency </plain></SENT>
<SENT sid="4" pm="."><plain>In the absence of Cyp-D, Col6a1(-/-) mice show negligible myofiber degeneration, rescue from <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction and ultrastructural defects, and normalized incidence of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>These findings (i) demonstrate that lack of Cyp-D is equivalent to its inhibition with CsA at curing the mouse dystrophic phenotype; (ii) establish a cause-effect relationship between Cyp-D-dependent <z:chebi fb="0" ids="52242">PTP</z:chebi> regulation and pathogenesis of the ColVI <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> and (iii) validate Cyp-D and the <z:chebi fb="0" ids="52242">PTP</z:chebi> as pharmacological targets for the therapy of human ColVI <z:hpo ids='HP_0003198'>myopathies</z:hpo> </plain></SENT>
</text></document>